Thoratec Corp. (THOR)’s HeartMate II, a device that pumps blood for patients with failing hearts, can form deadly blood clots, according to a report that urges investigation into therapeutic strategies to address the issue.
The implanted device caused 72 blood clots in 66 patients at three institutions, where 895 devices were implanted from 2004 through 2013, according to a study in the New England Journal of Medicine. The report pooled data from the Cleveland Clinic in Ohio, Washington University Barnes-Jewish Hospital in St. Louis, and Duke Medical University Center.
Help employers find you! Check out all the jobs and post your resume.
